Skip to Content

AptarGroup Inc ATR Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 125.04
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Blend
  • Day Range 124.79  –  126.83
  • Year Range 90.23  –  133.79
  • Market Cap 8.2073 Bil
  • Volume / Avg 330,916.0 /  292,117.0
  • Price / Sales 2.46
  • Price / Book 3.77
  • Forward Div Yield 1.34%
  • Trailing Div Yield 1.24%

Morningstar‘s Stock Analysis ATR

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Aptar's Pharma Division Positioned to Drive Long-Term Growth

Damien Conover Sector Director

Business Strategy and Outlook

| Damien Conover |

Aptar is a global leader in dispensing technologies and operates under three business segments, Aptar Pharma, Aptar Beauty, and Aptar Closures. The company specializes in nasal spray inhalers, high-end fragrance pumps, and food dispensing closures. While Aptar’s portfolio includes lower-margin products such as shampoo and soap pumps, it has intentionally focused on growing the higher-margin healthcare business over the past decade, and healthcare now accounts for two thirds of profits.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ATR

Company Profile ATR

Business Description

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

265 Exchange Drive, Suite 301
Crystal Lake, IL, 60014
Industry Medical Instruments & Supplies
Employees 13,500

Related Articles ATR

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of ATR’s competitive advantage.

AptarGroup Inc


West Pharmaceutical Services Inc


Insulet Corp


Stevanato Group SPA

−$0.43 (0.34%) −$3.87 (1.02%) −$4.37 (2.67%) +$0.16 (0.54%)
Market Cap
8.21 Bil27.71 Bil11.14 Bil8.78 Bil
Medical Instruments & Supplies Medical Instruments & Supplies Medical Devices Medical Instruments & Supplies

* Trading data in this section is delayed by at least 15 minutes.

FAQs for AptarGroup Inc Stock

Yes. ATR has a forward dividend yield of 1.31%. See ATR’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ATR’s market cap is 8.21 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ATR’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ATR’s price/sales is 2.46.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

ATR’s price/forward earnings is 33.17.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

ATR’s price/book is 3.77.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See ATR’s valuation ratios compared to the Market Index.

ATR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ATR’s historical performance against its industry peers and the overall market.